BACKGROUND: @entity110 is a common skin condition that causes significant impact on @entity1 's quality of life. OBJECTIVE: The purpose of the study was to assess adherence to therapy and quality of life of @entity1 with chronic @entity110 . We also aimed to study the relationship of medication adherence and quality of life of @entity1 with chronic @entity110 . METHODS: A cross sectional study was conducted with 103 @entity1 from the dermatology clinic of National University Hospital, Singapore. @entity1 with chronic @entity110 were asked to fill out a questionnaire for assessment of adherence to therapy and quality of life. We used the Morisky 8-Item Medication Adherence Scale to categorize adherence as high, medium, low. For assessment of quality of life, we used the validated chronic @entity110 quality of life questionnaire (CU-Q2oL) by Bairadani et al. RESULTS: The highest median scores for the items measuring quality of life were interference with sleep and @entity111 . We also observed that the majority of @entity1 (71.9%) had low adherence to medical therapy. No difference in adherence was noted in @entity1 on once daily medication or more frequent dosing. There was no significant difference in the quality of life among @entity1 with low and medium adherence to therapy. CONCLUSION: Quality of life of @entity1 with chronic @entity110 does not depend on the @entity1 ' adherence to medications. Dosing frequency does not affect adherence in our study population. It is also important to recognize the symptoms and issues most affecting quality of life of @entity1 with chronic @entity110 , so as to improve overall management.

A study of treatment adherence and quality of life among adults with chronic XXXX in Singapore.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity110 :: ('MESH:D014581', 'Disease') :: ['Chronic urticaria', 'urticaria'] @entity111 :: ('MESH:D011537', 'Disease') :: ['pruritus']
@entity110 :: (MESH:D014581,Disease) :: ['urticaria']
